Superstring Capital Management as of Dec. 31, 2025
Portfolio Holdings for Superstring Capital Management
Superstring Capital Management holds 45 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cidara Therapeutics Com New (CDTX) | 10.1 | $19M | 85k | 220.89 | |
| Terns Pharmaceuticals (TERN) | 9.6 | $18M | 444k | 40.40 | |
| Urogen Pharma (URGN) | 9.0 | $17M | 718k | 23.42 | |
| Cogent Biosciences (COGT) | 7.0 | $13M | 366k | 35.52 | |
| Dynavax Technologies Corp Com New (DVAX) | 4.3 | $8.1M | 526k | 15.38 | |
| Sionna Therapeutics (SION) | 4.0 | $7.4M | 181k | 41.14 | |
| Immunovant (IMVT) | 3.9 | $7.3M | 289k | 25.42 | |
| Axsome Therapeutics (AXSM) | 3.7 | $6.8M | 37k | 182.64 | |
| Savara (SVRA) | 3.2 | $6.0M | 995k | 6.03 | |
| Mind Medicine Mindmed Com New (MNMD) | 3.0 | $5.7M | 425k | 13.39 | |
| Taysha Gene Therapies Com Shs (TSHA) | 2.9 | $5.4M | 981k | 5.50 | |
| Ocular Therapeutix (OCUL) | 2.7 | $5.1M | 418k | 12.14 | |
| Amicus Therapeutics (FOLD) | 2.7 | $5.0M | 353k | 14.24 | |
| Cabaletta Bio (CABA) | 2.6 | $4.9M | 2.3M | 2.19 | |
| United Therapeutics Corporation (UTHR) | 2.5 | $4.6M | 9.5k | 487.25 | |
| Revolution Medicines (RVMD) | 2.3 | $4.4M | 55k | 79.65 | |
| Belite Bio Sponsored Ads (BLTE) | 2.1 | $4.0M | 25k | 159.96 | |
| Bright Minds Biosciences Com New (DRUG) | 2.0 | $3.7M | 47k | 78.04 | |
| Zai Lab Adr (ZLAB) | 1.9 | $3.5M | 197k | 17.64 | |
| Zenas Biopharma (ZBIO) | 1.6 | $3.0M | 83k | 36.31 | |
| Cortexyme (QNCX) | 1.5 | $2.9M | 859k | 3.35 | |
| Avalo Therapeutics Com New (AVTX) | 1.5 | $2.8M | 153k | 18.16 | |
| Capricor Therapeutics Com New (CAPR) | 1.5 | $2.8M | 96k | 28.86 | |
| Palvella Therapeutics Inc Ne (PVLA) | 1.4 | $2.7M | 26k | 104.67 | |
| Celldex Therapeutics Com New (CLDX) | 1.3 | $2.4M | 88k | 27.16 | |
| Assembly Biosciences Com New (ASMB) | 1.2 | $2.2M | 65k | 34.01 | |
| Oric Pharmaceuticals (ORIC) | 1.1 | $2.1M | 255k | 8.18 | |
| Protara Therapeutics Com Stk (TARA) | 1.0 | $1.9M | 360k | 5.33 | |
| Trevi Therapeutics (TRVI) | 1.0 | $1.9M | 148k | 12.52 | |
| Tyra Biosciences (TYRA) | 0.8 | $1.5M | 59k | 26.29 | |
| Travere Therapeutics (TVTX) | 0.8 | $1.5M | 38k | 38.21 | |
| Miragen Therapeutics (VRDN) | 0.7 | $1.3M | 43k | 31.12 | |
| Rezolute Com New (RZLT) | 0.6 | $1.2M | 514k | 2.36 | |
| Dianthus Therapeutics (DNTH) | 0.6 | $1.1M | 26k | 41.21 | |
| Spruce Biosciences Com New (SPRB) | 0.6 | $1.1M | 12k | 87.11 | |
| Aardvark Therapeutics (AARD) | 0.5 | $912k | 70k | 13.12 | |
| Genmab A/s Sponsored Ads (GMAB) | 0.5 | $898k | 29k | 30.80 | |
| Palisade Bio (PALI) | 0.5 | $863k | 367k | 2.35 | |
| Fulcrum Therapeutics (FULC) | 0.4 | $815k | 72k | 11.31 | |
| Ultragenyx Pharmaceutical (RARE) | 0.4 | $730k | 32k | 23.00 | |
| Palatin Technologies Com New (PTN) | 0.3 | $523k | 34k | 15.38 | |
| Inventiva Sa Ads (IVA) | 0.2 | $465k | 100k | 4.65 | |
| Century Therapeutics (IPSC) | 0.2 | $461k | 463k | 0.99 | |
| Biomea Fusion (BMEA) | 0.2 | $310k | 250k | 1.24 | |
| Entera Bio SHS (ENTX) | 0.0 | $33k | 17k | 1.94 |
